Verition Fund Management’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-19,847
| Closed | -$960K | – | 3044 |
|
|
2025
Q1 | $960K | Buy |
+19,847
| New | +$960K | ﹤0.01% | 1646 |
|
|
2024
Q3 | – | Sell |
-10,895
| Closed | -$378K | – | 2723 |
|
|
2024
Q2 | $378K | Buy |
10,895
+1,713
| +19% | +$59.4K | ﹤0.01% | 1599 |
|
|
2024
Q1 | $266K | Buy |
+9,182
| New | +$266K | ﹤0.01% | 1764 |
|
|
2023
Q3 | – | Sell |
-9,210
| Closed | -$254K | – | 2210 |
|
|
2023
Q2 | $254K | Buy |
+9,210
| New | +$254K | ﹤0.01% | 1447 |
|